101 related articles for article (PubMed ID: 6887938)
1. Treatment outcome of recurrent cervical cancer.
Chung CK; Nahhas WA; Stryker JA; Mortel R
J Surg Oncol; 1983 Sep; 24(1):5-10. PubMed ID: 6887938
[TBL] [Abstract][Full Text] [Related]
2. Salvage radiotherapy with or without concurrent chemotherapy for pelvic recurrence after hysterectomy alone for early-stage uterine cervical cancer.
Kim SW; Chun M; Ryu HS; Chang SJ; Kong TW; Lee EJ; Lee YH; Oh YT
Strahlenther Onkol; 2017 Jul; 193(7):534-542. PubMed ID: 28357468
[TBL] [Abstract][Full Text] [Related]
3. [Pelvic wall recurrence of cervix carcinomas. Combined surgical-radio-chemotherapeutic procedure (CORCT)].
Schulz-Wendtland R; Krämer S; Säbel M; Heller F; Keilholz L; Jäger W; Sauer R; Lang N; Bautz W
Strahlenther Onkol; 1998 May; 174(5):279-83. PubMed ID: 9614958
[TBL] [Abstract][Full Text] [Related]
4. Optimal therapy for pelvic recurrence after radical hysterectomy for early-stage cervical cancer.
Potter ME; Alvarez RD; Gay FL; Shingleton HM; Soong SJ; Hatch KD
Gynecol Oncol; 1990 Apr; 37(1):74-7. PubMed ID: 2323616
[TBL] [Abstract][Full Text] [Related]
5. The Treatment of Pelvic Locoregional Recurrence of Cervical Cancer After Radical Surgery With Intensity-Modulated Radiation Therapy Compared With Conventional Radiotherapy: A Retrospective Study.
Yin YJ; Li HQ; Sheng XG; Du XL; Wang C; Lu CH; Pan CX
Int J Gynecol Cancer; 2015 Jul; 25(6):1058-65. PubMed ID: 25647254
[TBL] [Abstract][Full Text] [Related]
6. Impact of the addition of concurrent chemotherapy to pelvic radiotherapy in surgically treated stage IB1-IIB cervical cancer patients with intermediate-risk or high-risk factors: a 13-year experience.
Okazawa M; Mabuchi S; Isohashi F; Suzuki O; Yoshioka Y; Sasano T; Ohta Y; Kamiura S; Ogawa K; Kimura T
Int J Gynecol Cancer; 2013 Mar; 23(3):567-75. PubMed ID: 23385284
[TBL] [Abstract][Full Text] [Related]
7. [Analysis of prognostic factors and therapeutic patterns of recurrent stage Ⅰb-Ⅱa cervical squamous carcinoma treated with radical hysterectomy].
Ou ZJ; Zhao D; An JS; Sun CY; Huang MN; Li B; Wu LY
Zhonghua Fu Chan Ke Za Zhi; 2019 Jun; 54(6):399-405. PubMed ID: 31262124
[No Abstract] [Full Text] [Related]
8. Radiation therapy of pelvic recurrence after radical hysterectomy for cervical carcinoma.
Ijaz T; Eifel PJ; Burke T; Oswald MJ
Gynecol Oncol; 1998 Aug; 70(2):241-6. PubMed ID: 9740698
[TBL] [Abstract][Full Text] [Related]
9. Management of recurrent cervical cancer.
Lai CH
Chang Gung Med J; 2004 Oct; 27(10):711-7. PubMed ID: 15646293
[TBL] [Abstract][Full Text] [Related]
10. A retrospective review of patients with stage IB2 cervical cancer treated with radical radiation versus radical surgery as a primary modality.
Alleyne-Mike K; van Wijk L; Hunter A
Int J Gynecol Cancer; 2013 Sep; 23(7):1287-94. PubMed ID: 23863456
[TBL] [Abstract][Full Text] [Related]
11. State-of-the-Art Treatment and Novel Agents in Local and Distant Recurrences of Cervical Cancer.
Tempfer CB; Beckmann MW
Oncol Res Treat; 2016; 39(9):525-33. PubMed ID: 27614445
[TBL] [Abstract][Full Text] [Related]
12. Indications for primary and secondary exenterations in patients with cervical cancer.
Marnitz S; Köhler C; Müller M; Behrens K; Hasenbein K; Schneider A
Gynecol Oncol; 2006 Dec; 103(3):1023-30. PubMed ID: 16890276
[TBL] [Abstract][Full Text] [Related]
13. Survival after curative pelvic exenteration for primary or recurrent cervical cancer: a retrospective multicentric study of 167 patients.
Chiantera V; Rossi M; De Iaco P; Koehler C; Marnitz S; Ferrandina G; Legge F; Parazzini F; Scambia G; Schneider A; Vercellino GF
Int J Gynecol Cancer; 2014 Jun; 24(5):916-22. PubMed ID: 24442006
[TBL] [Abstract][Full Text] [Related]
14. Effects of Neoadjuvant Chemotherapy Plus Radical Surgery as Front Line Treatment Strategy in Patients Affected by FIGO Stage III Cervical Cancer.
Di Donato V; Schiavi MC; Ruscito I; Visentin VS; Palaia I; Marchetti C; Fischetti M; Monti M; Muzii L; Benedetti Panici P
Ann Surg Oncol; 2016 Dec; 23(Suppl 5):841-849. PubMed ID: 27678502
[TBL] [Abstract][Full Text] [Related]
15. A pilot study of adjuvant therapy in patients with cervical cancer at high risk of recurrence after radical hysterectomy and pelvic lymphadenectomy.
Wertheim MS; Hakes TB; Daghestani AN; Nori D; Smith DH; Lewis JL
J Clin Oncol; 1985 Jul; 3(7):912-6. PubMed ID: 2410573
[TBL] [Abstract][Full Text] [Related]
16. [Clinical analysis of 32 cases with neuroendocrine carcinoma of the uterine cervix in early-stage disease].
Wang Z; Wu L; Yao H; Sun Y; Li X; Li B; Zhang R; Ma S; Huang M
Zhonghua Fu Chan Ke Za Zhi; 2015 Mar; 50(3):198-203. PubMed ID: 26268410
[TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant chemotherapy followed by radical surgery and radiotherapy vs. pelvic irradiation in patients with cervical cancer FIGO stage IIB - IVA.
Kornovski Y; Gorchev G
J BUON; 2006; 11(3):291-7. PubMed ID: 17309152
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant Small Pelvic Radiotherapy in Patients with Cervical Cancer Having Intermediate Risk Factors Only - Is It Sufficient?
Yuce Sari S; Guler OC; Gultekin M; Onal HC; Yildiz F
Oncol Res Treat; 2017; 40(9):523-527. PubMed ID: 28848218
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors in FIGO stage IB cervical cancer without lymph node metastasis and the role of adjuvant radiotherapy after radical hysterectomy.
Ayhan A; Al RA; Baykal C; Demirtas E; Ayhan A; Yüce K
Int J Gynecol Cancer; 2004; 14(2):286-92. PubMed ID: 15086728
[TBL] [Abstract][Full Text] [Related]
20. Early stage cervical cancer: Brachytherapy followed by type a hysterectomy versus type B radical hysterectomy alone, a retrospective evaluation.
Lacorre A; Merlot B; Garabedian C; Narducci F; Chereau E; Resbeut M; Minsat M; Leblanc E; Houvenaeghel G; Lambaudie E
Eur J Surg Oncol; 2016 Mar; 42(3):376-82. PubMed ID: 26725307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]